Therapeutic Solutions International, Inc. – OTC:TSOI
Therapeutic Solutions International stock price today
Therapeutic Solutions International stock price monthly change
Therapeutic Solutions International stock price quarterly change
Therapeutic Solutions International stock price yearly change
Therapeutic Solutions International key metrics
Market Cap | 12.51M |
Enterprise value | 7.63M |
P/E | -1.20 |
EV/Sales | 23.09 |
EV/EBITDA | -2.02 |
Price/Sales | 19.89 |
Price/Book | 4.74 |
PEG ratio | 0.08 |
EPS | -0.33 |
Revenue | 47.59M |
EBITDA | -1.13B |
Income | -1.18B |
Revenue Q/Q | 94238.96% |
Revenue Y/Y | 32725.35% |
Profit margin | -1655.35% |
Oper. margin | -1417.01% |
Gross margin | 68.5% |
EBIT margin | -1417.01% |
EBITDA margin | -2377.43% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTherapeutic Solutions International stock price history
Therapeutic Solutions International stock forecast
Therapeutic Solutions International financial statements
| Jun 2023 | 26.30K | -562.4K | -2137.75% |
|---|---|---|---|
| Sep 2023 | 25.73M | -602.04M | -2339.84% |
| Dec 2023 | 23.83K | -427.49K | -1793.7% |
| Mar 2024 | 21.81M | -585.14M | -2682.41% |
| Jun 2023 | 3487420 | 1.99M | 57.24% |
|---|---|---|---|
| Sep 2023 | 3474377 | 2.16M | 62.32% |
| Dec 2023 | 3313012 | 2.01M | 60.67% |
| Mar 2024 | 4069035 | 2.04M | 50.2% |
| Jun 2023 | -337.10K | -2.75K | 433.40K |
|---|---|---|---|
| Sep 2023 | -311.08K | -18.86K | 297.00K |
| Dec 2023 | -206.02K | -4.33K | 147.65K |
| Mar 2024 | -205.50K | 0 | 231.16K |
Therapeutic Solutions International alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
Therapeutic Solutions International other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2013 | 0 | 1363950 |
| Mar 2014 | 0 | 1494664 |
| Apr 2014 | 0 | 530714 |
| Insider | Compensation |
|---|---|
Mr. Timothy George Dixon (1958) Chairman, Chief Executive Officer & Pres | $220,000 |
-
What's the price of Therapeutic Solutions International stock today?
One share of Therapeutic Solutions International stock can currently be purchased for approximately $0.
-
When is Therapeutic Solutions International's next earnings date?
Unfortunately, Therapeutic Solutions International's (TSOI) next earnings date is currently unknown.
-
Does Therapeutic Solutions International pay dividends?
No, Therapeutic Solutions International does not pay dividends.
-
How much money does Therapeutic Solutions International make?
Therapeutic Solutions International has a market capitalization of 12.51M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 52.12% to 98.99K US dollars.
-
What is Therapeutic Solutions International's stock symbol?
Therapeutic Solutions International, Inc. is traded on the OTC under the ticker symbol "TSOI".
-
What is Therapeutic Solutions International's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Therapeutic Solutions International?
Shares of Therapeutic Solutions International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Therapeutic Solutions International's key executives?
Therapeutic Solutions International's management team includes the following people:
- Mr. Timothy George Dixon Chairman, Chief Executive Officer & Pres(age: 67, pay: $220,000)
-
How many employees does Therapeutic Solutions International have?
As Jul 2024, Therapeutic Solutions International employs 3 workers.
-
When Therapeutic Solutions International went public?
Therapeutic Solutions International, Inc. is publicly traded company for more then 17 years since IPO on 24 Jun 2008.
-
What is Therapeutic Solutions International's official website?
The official website for Therapeutic Solutions International is therapeuticsolutionsint.com.
-
Where are Therapeutic Solutions International's headquarters?
Therapeutic Solutions International is headquartered at 4093 Oceanside Boulevard, Oceanside, CA.
-
How can i contact Therapeutic Solutions International?
Therapeutic Solutions International's mailing address is 4093 Oceanside Boulevard, Oceanside, CA and company can be reached via phone at +7 602957208.
Therapeutic Solutions International company profile:
Therapeutic Solutions International, Inc.
therapeuticsolutionsint.comOTC
3
Biotechnology
Healthcare
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPlus, a blend of NanoStilbene and Nano Cannabidiol; Nano Cannabidiol, a nanoparticle formulation of cannabidiol; NanoPSA, a blend of NanoStilbene and broccoli sprout extract; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. It is also developing therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho.
Oceanside, CA 83525
CIK: 0001419051
ISIN: US8833781011
CUSIP: 883378101
